Therefore, poor prognosis patients with low ALOX12B expression had high infiltration of CAFs surrounding tumor cells, and rapamycin or everolimus may provide survival benefits by inhibiting mTOR signaling. This evidence concerns the gene ALOX12B and neoplasm.